Prices delayed by at least 15 minutes | Print


Genflow Biosciences PLC (GENF)

ORD GBP0.0003
Sell: 0.95p|Buy: 1.10p|Change: 0 (0%)

Open 

1.025p


Previous close 

1.025p


Trade high 

1.0849p


Volume 

523,387


Year high 

3.406p


Year low 

0.9555p


Dividend yield 


Market capitalisation 

£4.01 mn


P/E ratio 


ISIN 

GB00BP2C3V08


Share price

Performance 30/04/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Genflow Biosciences PLC- 2.38
More...

Company profile

Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process and reducing the incidence ofage-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.

Sector 

Healthcare


News

Recent trades

DateTimePriceQuantityValue (£)
01/05/202502:51:350.97550,000487.50
01/05/202502:29:260.9733330,000292.00
01/05/202502:19:570.973335,00048.67
01/05/202502:08:190.97536,970360.46
01/05/202512:49:461.08493663.97

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.